Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device FDA regulatory submission for the Company’s Genio® device is complete, U.S. approval on track for the end of 2024 U.S. commercial launch, expected at the beginning of…
![EFI](https://usercontent.one/wp/www.fininfo.be/wp-content/uploads/2022/10/cropped-siteicon-alt@3x.png?media=1721287019)
EFI03 September 2024